AGN 8.61% 82.0¢ argenica therapeutics limited

Ann: Successful Completion of Phase 1 Clinical Trial Dosing, page-42

  1. 1,981 Posts.
    lightbulb Created with Sketch. 434
    It's a biotech.....no rational reason but it keeps moving..

    key is good news and long term.....

    looking back, should have sold when it touched close to 90c....

    I am sure it will go back there in time with positive news
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.